Login to Your Account



TKT To Cut 100 Employees, Search For Partnerships

By Aaron Lorenzo


Thursday, March 20, 2003
One hundred people have received notice of their layoffs from Transkaryotic Therapies Inc. as the company works to tighten its focus two months after receiving a negative FDA committee vote on its lead product, Replagal. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription